Analyst Ratings for Rexahn Pharmaceuticals Inc. (RNN)
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/28/2018 | Brookline Capital Markets | Kumaraguru Raja | New Coverage | Buy (N/A) |
10.00 (N/A) |
1.11 (5.24) |
372.07% | Details |
10/4/2018 | IFS Securities | David Bouchey | Upgrade | Strong Buy (Outperform) |
6.00 (N/A) |
1.85 (5.24) |
183.24% | Details |